JOHN E. REPINE, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2006-06-15 John E. Repine, M.D. (1) 61 Director 2005 (1) Member of the Audit Committee
2007-09-19 John E. Repine, M.D. (1) 62 Director 2005 (1) Member of the Audit Committee ... Total $21,874 ... Includes 39,925 shares of common stock valued at $7,785 on the date of the grant, as compensation under a consulting agreement ... Total $34,659

Data sourced from SEC filings. Last updated: 2025-08-30